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ABSTRACT
Objectives: Population-based health risk assessment
and stratification are considered highly relevant for
large-scale implementation of integrated care by
facilitating services design and case identification. The
principal objective of the study was to analyse five
health-risk assessment strategies and health indicators
used in the five regions participating in the Advancing
Care Coordination and Telehealth Deployment (ACT)
programme (http://www.act-programme.eu). The
second purpose was to elaborate on strategies toward
enhanced health risk predictive modelling in the clinical
scenario.
Settings: The five ACT regions: Scotland (UK), Basque
Country (ES), Catalonia (ES), Lombardy (I) and
Groningen (NL).
Participants: Responsible teams for regional data
management in the five ACT regions.
Primary and secondary outcome measures: We
characterised and compared risk assessment strategies
among ACT regions by analysing operational health risk
predictive modelling tools for population-based
stratification, as well as available health indicators at
regional level. The analysis of the risk assessment tool
deployed in Catalonia in 2015 (GMAs, Adjusted
Morbidity Groups) was used as a basis to propose
how population-based analytics could contribute to
clinical risk prediction.
Results: There was consensus on the need for a
population health approach to generate health risk
predictive modelling. However, this strategy was fully
in place only in two ACT regions: Basque Country and
Catalonia. We found marked differences among regions
in health risk predictive modelling tools and health
indicators, and identified key factors constraining their
comparability. The research proposes means to
overcome current limitations and the use of
population-based health risk prediction for enhanced
clinical risk assessment.
Conclusions: The results indicate the need for further
efforts to improve both comparability and flexibility of
current population-based health risk predictive
modelling approaches. Applicability and impact of the
proposals for enhanced clinical risk assessment require
prospective evaluation.
INTRODUCTION
Large scale deployment and adoption of
integrated care services in Europe seek
health efﬁciencies with simultaneous reduc-
tion of outcome variability within and among
regions.1–4 It is well recognised that health
risk assessment can be relevant for regional
adoption of integrated care5–7 because of its
impact on the design of healthcare services,
as well as for stratiﬁcation and clinical man-
agement of chronic patients.6 8 9
Strengths and limitations of this study
▪ The manuscript compares five population-based
health risk assessment and stratification strat-
egies placed in five European regions leading
deployment of integrated care for chronic
patients.
▪ Characteristics of population-based health risk
predictive modelling tools limiting comparability
across regions and precluding their adaptation to
evolving needs are explored.
▪ A conceptual approach making use of the poten-
tial of population-based health risk prediction to
enhance clinical risk predictive modelling is
formulated.
▪ A conceptual frame for dynamic integration of
heterogeneous data to pave the way toward per-
sonalised medicine is proposed.
▪ Validation and implementation of the study pro-
posals require further work beyond the scope of
the current research.
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The current study was carried out within the frame of
the Advancing Care Coordination and Telehealth (ACT)
programme (http://www.act-programme.eu)9 involving
ﬁve leading European Union (EU) regions in terms of
scaling up integrated care: Basque Country (ES),
Scotland (UK), Lombardy (I), Groningen (NL) and
Catalonia (ES). Integrated care was deﬁned as the
organisation of activities among participants involved in
a patient’s care to facilitate the appropriate delivery of
healthcare services.9
The 2.5-year ACT programme, initiated in 2013,
explored the organisational and structural processes
needed to successfully implement integrated care ser-
vices on a large scale. By speciﬁcally investigating four
key drivers inﬂuencing the effective deployment of inte-
grated care services and generating ‘best practice’ exam-
ples, ACT intended to provide the foundation to help
overcome current barriers for extensive adoption of inte-
grated care. The four key drivers addressed in the ACT
programme were: risk assessment and stratiﬁcation,
workﬂows and organisational structures, staff engage-
ment and patient adherence.
In the healthcare services domain, population-based
risk predictive modelling facilitates the elaboration of
stratiﬁcation maps characterising risk strata distribution
of the entire population in a given geographic
location. It allows identiﬁcation of subsets of citizens
with similar healthcare requirements facilitating both
case ﬁnding and screening. The former, case ﬁnding,
identiﬁes highly vulnerable patients, allocated at the tip
of the risk pyramid, who are prone to major deleteri-
ous health events such as unplanned hospital admis-
sions/readmissions, fast functional decline and/or
death.10 11 Likewise, performing screening for discovery
of cases with non-manifest illnesses may beneﬁt
from early diagnosis and cost-effective preventive
interventions.6
In the clinical management domain, risk prediction of
well-deﬁned medical problems (ie, prediction of survival
in acute exacerbations of chronic obstructive pulmonary
disease (COPD))12 can support health professionals in
the decision-making process. Moreover, clinical risk pre-
diction may contribute to patient classiﬁcation in the
optimal healthcare tier, helping to deﬁne shared care
arrangements between primary care and specialists.
However, it is acknowledged that modelling tools addres-
sing speciﬁc clinical issues with a high predictive power
may present limitations for their general application
outside the source population.7 13
The study, therefore, addresses two speciﬁc aims. First,
to analyse population-based health risk assessment strat-
egies, including assessment tools and health indicators,
in the ﬁve ACT regions, in order to identify current bar-
riers and to elaborate recommendations for large scale
deployment of integrated care at the European level.
The second aim was to elaborate on strategies toward
enhanced health risk predictive modelling in the clinical
scenario.
METHODS
Whereas the general characteristics of the population
and healthcare organisation of these ﬁve regions have
been reported in detail elsewhere,9 the analysis of
population-based health risk assessment and stratiﬁca-
tion strategies in place in the ﬁve ACT regions was
carried out focusing on two speciﬁc components: (1)
analysis of health risk predictive modelling tools and (2)
comparison of reported health indicators. The latter was
addressed to assess comparability of health status among
regions. Finally, a use case to analyse the potential for
innovation in population-based health risk prediction
was identiﬁed and explored.
Population-based health risk predictive modelling
We performed a two-phase survey approximately
8 months apart (Summer 2014 and Spring 2015),
addressing the person responsible for the development/
maintenance of the risk assessment strategy in each of
the ﬁve ACT regions. The ﬁve persons (see acknowledge-
ments) were fully accessible through the duration of the
project, but the interviews were naturally grouped in two
periods, as described above. Details on the character-
istics of the survey are reported in the on-line online
supplementary material (part I, pages 1 to 24).
In the ﬁrst survey, systematic responses to a standar-
dised questionnaire elaborated for this purpose by
Opimec14 were collected. Participants answered the
questionnaire by mail and subsequently underwent an
interview. We captured information on several key
dimensions characterising the risk predictive modelling
tools, namely: (1) modelling approach, (2) source
sample, (3) main and summary statistics, (4) outcome
(dependent) variables and covariates, (5) update period-
icity, (6) target population and (7) maturity of clinical
implementation. This facilitated the elaboration of an
initial map of regional practices.
The second survey had a twofold purpose: (1) to ﬁll
speciﬁc information gaps identiﬁed after the ﬁrst survey
and (2) to ask additional questions inquiring on existing
plans for evolving the risk predictive modelling tool in
place. Also, we assessed the potential for transferability
across regions at EU level. The core objective of the
second survey was to elaborate on future strategies to
overcome limitations of current population-based risk
assessment tools that were identiﬁed during the ﬁrst
survey. To this end, four main items were analysed: (1)
openness of algorithms, (2) ﬂexibility for adjustments to
other populations, (3) license costs associated with the
use of the case ﬁnding tool and (4) licence agreements
binding its applicability to speciﬁc territories.
The comparative analyses of health risk assessment
tools among ACT regions were carried out taking into
account a clear distinction regarding the characteristics
of the source population. That is, health risk assessment
tools generated from modelling the entire population of
a given region (or geographical area) with a holistic
approach were considered to follow a population health
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approach, as proposed by Kindig and Stoddart in 2003.15
On the other hand, health risk assessments derived from
modelling patient populations were regarded as follow-
ing a population medicine approach.16
Owing to our interest in case ﬁnding and screening
analyses, the current study focused on healthcare fore-
casting17 that implies predicting an individual’s health-
care utilisation for interventional purposes with either
preventive or therapeutic goals. Comprehensive descrip-
tions of the characteristics of health risk predictive mod-
elling and the logistics required for deployment are
reported elsewhere.18–20 It is of note that other analyses
such as risk adjustment21–23 or actuarial approaches24
were not considered in the current research.
Health indicators
One of the initial goals of the ACT programme was to
identify a common set of indicators useful to evaluate
the impact of health interventions at population level in
order to facilitate comparability of the effects of inte-
grated care services over time within and across regions.
As a ﬁrst step of this objective, a semistructured ques-
tionnaire including indicators to evaluate health status
at population level was sent via email to the ACT coord-
inator in each of the ﬁve regions. The speciﬁc objective
of the questionnaire was to assess comparability of
health status across regions at baseline. The character-
istics and dimensions covered by the questionnaire are
reported in detail in the online supplementary material
(part II, table 1S). The indicators selected in the
current study were shared by the ﬁve ACT regions and
had been previously deﬁned and agreed within the
consortium.
Overcoming current limitations of health risk assessment
tools
In 2015, a novel population-based health risk assessment
tool (GMAs, Adjusted Morbidity Groups) was deployed
in Catalonia (see online supplementary material tables
2S-3S and ﬁgures 1S and 2S). The deployment included
display of the GMA stratiﬁcation results in the clinical
workstation used by primary care physicians.
The GMAs were developed independently from the
ACT programme. It is of note, however, that the evalu-
ation of this risk assessment tool, carried out before its
regional deployment, provide the basis to generate a
proposal for enhanced health risk predictive modelling
in the clinical setting.
The performance of the GMAs was compared with the
results of the Clinical Risk Groups (CRGs) risk predictive
model,25 used in Catalonia until 2014, through two com-
plementary approaches: (1) statistical evaluation asses-
sing prediction of relevant healthcare outcomes, namely:
mortality, unplanned admissions, emergency department
consultations and healthcare expenditure (ﬁgure 1), and
(2) clinical evaluation carried out by general practi-
tioners. The latter consisted of a comparative clinical
evaluation of GMA and CRG classiﬁcations blindly under-
taken by 40 general practitioners examining electronic
health records from 1000 cases (25 cases per general
practitioner; see online supplementary ﬁgure 3S).
RESULTS
Population-based health risk assessment tools
The main characteristics of the health risk predictive
modelling tools in place in four out the ﬁve ACT regions
Figure 1 Explained variability indicated by R2 (expressed as a percentage) in the y-axis, for four main outcomes: mortality,
hospital admissions, emergency department visits and total healthcare expenses obtained from the analysis of the Catalan
population (7.5 million inhabitants) in 2014, using three different health risk assessment models built-up with different covariates:
A+S+SE includes only age, sex and socioeconomic status as covariates; A+S+SE+CRG additionally includes Clinical Risk
Groups as morbidity grouper25 and A+S+SE+GMA includes information from Adjusted Morbidity Groups as morbidity grouper
(see online supplementary material for further details, part I).
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are depicted in table 1. Groningen (NL) is not repre-
sented because the site does not use any popula-
tion-based health risk predictive modelling for the two
integrated care programmes currently deployed.9
Instead, Groningen prioritised individual health risk
characterisation based on information collected in the
electronic health records.
Table 1 indicates that a population health approach15
is currently only adopted in the Basque Country26–29
and in Catalonia. Since 2010, Scotland30 is clearly evolv-
ing in this direction. The source population of the
current health risk predictive modelling tool already
covers 63% of the entire Scottish population.
Strategically, it is moving from a strong focus on use of
hospital-related resources (eg, emergency department
consultations, unplanned hospital admissions and/or
early readmissions) toward integration of needs for frail
patients, including social support and long-term care.
Periodic updates are carried out in the three regions.
In contrast, Lombardy31 has a population medicine
approach consisting of a classiﬁcation system based on
stratiﬁcation by health costs. It serves the coordinated
care programme for chronic patients, especially those
with conditions such as COPD, cardiovascular disorders
and diabetes mellitus types I and II.
The analysis of the risk-strata distributions resulting
from the different regions showed poor comparability
(table 2). This is explained by differences among risk
predictive modelling tools, and by the diverse classiﬁca-
tion criteria used to deﬁne risk groups.32
We identiﬁed signiﬁcant constraints for transferability
across regions due to three main factors, namely: (1)
lack of openness of algorithms, (2) inclusion of expert-
based criteria in the morbidity groupers and (3) license
bindings constraining applicability of health risk assess-
ment tools to other EU regions. It is of note that only
Catalonia and Scotland (table 2) have white-box tools
owned by the regions, which, in principle, implies high
potential to properly deal with the limitations for such
transferability.
We identiﬁed a consensus on the need for transferring
information on high-risk patients to practising clinicians
in order to trigger preventive interventions and to
support clinical decision-making processes. However, we
observed different degrees of maturity in the interac-
tions with clinicians, from only providing a list of high-
risk candidates for interventions to the display of simple
clinical decision support systems in the clinical worksta-
tion of primary care physicians.
Despite the actual differences among the ﬁve ACT
regions, the two surveys showed consensus in the basic
aspects, indicated (in table 3) that they should be
covered by an ideal health-risk assessment strategy
showing transferability among regions and potential to
generate synergies with clinical risk predictive models.
The practicalities for deployment of health risk assess-
ment tools at regional level are summarised in online
supplementary table 4S.
Health indicators
The list of recommended indicators identiﬁed by the
consortium is included in the online supplementary
material. We found that, despite availability of most of
the data at the regional level, two main limiting factors
precluded baseline comparisons among the regions,
namely: (1) insufﬁcient data harmonisation (eg, differ-
ent versions of International Classiﬁcation of Diseases
(ICD) coding)33 and (2) differences in data reporting
(ie, different levels of data aggregation and/or differ-
ences in calculation of complex indices). The outcome
of the baseline assessment did not allow completion of
the initial ACT plan on health indicators described in
the Methods section.
The GMA as a use case
Among the different population-based health risk as-
sessment tools evaluated in ACT (table 1), only GMA as
the novel predictive modelling tool deployed in
Catalonia34 35 complied with the main characteristics
recommended in table 3. The current GMA version
covers four key requirements: (1) a population health
approach using the entire source population of 7.5
million inhabitants of the region, with a bi-annual update
of the risk pyramid distribution, (2) publicly owned
without licensing constraints, (3) open source computa-
tional algorithms and (4) that the GMA morbidity
grouper relies only on statistical criteria thus facilitating
quick adaptation to different territories. Accordingly, it
was selected as a use case for the analysis carried out in
the current section.
Figure 1 illustrates the percentage of explained vari-
ability by GMA for four relevant outcomes, namely: mor-
tality, hospital admissions, emergency department
admissions and total healthcare expenses. It is of note
that GMAs accounted for a higher percentage of vari-
ability than did CRGs.25 Additionally, the results of the
analysis of concordance among clinical evaluators indi-
cated that the two morbidity groupers (GMA and CRG)
agreed with clinicians in the classiﬁcation of the cases by
complexity, but GMAs showed a better performance in
the strata of greater complexity (see online
supplementary ﬁgure 3S). Moreover, in most cases, clin-
ical evaluators preferred GMAs.
Overall, the GMA shows ﬂexibility and transferability,
as demonstrated by its recent adoption by 13 of the 17
regional healthcare systems in Spain, covering 92% of
the overall Spanish population, approximately 38 million
citizens. Consequently, the GMA can be considered a
health risk assessment model that overcomes the main
limitations identiﬁed in the current study. Accordingly, it
seems suited to aid future assessment of the potential of
population-based risk assessment and enhance clinical
risk modelling. To this end, the steps that should be ful-
ﬁlled in order to shape the proposal are described below.
Statistical reﬁnement of the computational modelling
of the current GMA,36 in order to generate an enhanced
GMA personalising current information on socioeconomic
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Table 1 Risk predictive modelling tools in the ACT regions*
Basque Catalonia Lombardy Scotland
Model Predictive (based in Adjusted Clinical
Groups-Predictive Model ACG-PM)
Predictive (based in the self-developed
model GMA) (until 2014, use of the 3M
Clinical Risk Groups, 3M-CRG)
Classificatory (based in the
Diagnosis-Related Group, DRG,
and a self-developed scheme
CReG)
Predictive (Scottish Patients at
Risk of Readmission and
Admission, SPARRA-3)
Source
population
Entire population of the Basque
Country (2 100 000 citizens)
Entire population of Catalonia
(7 500 000 citizens)
Patient group attended by one
Primary Care provider (GReG
cohort) (100 000 patients)
Data base of patients attended
by NHS24 (3 400 000
patients)†
Updates Annual Semester Once Monthly
Scope of the use Population-based risk assessment and
stratification for health policy and
service design, as well as use as case
finding tool
Population-based risk assessment and
stratification for health policy and
service design, as well as use as case
finding tool
Case finding tool and
reimbursement model
Case finding tool
Clinical
application
▸ All levels of care can see the same
information.
▸ Practising physicians receive a risk
score for each patient
▸ All levels of care can see the same
information.
▸ Practising physicians and nurses
receive a risk score for each patient
▸ All levels of care can see the
same information.
▸ Practising physicians receive a
risk score for each patient
▸ All levels of care can see
the same information.
▸ Practising Physicians
receive a risk score for
each patient
Outcomes
(dependent
variables)
Mainly: health costs Mainly: unscheduled hospital
admissions at 1 year, readmission at
180 days and risk of death at
12 months
Costs of pharmacy, outpatient and
inpatient costs
Individual’s risk of emergency
hospital inpatient admission
over the next 12 months
Risk of Institutionalisation
Covariates
(independent
variables)
Demographic information
Diagnosis
Comorbidity using a grouper
Past healthcare consumption
Aggregated socioeconomic status
Demographic information
Diagnosis
Comorbidity using a grouper
Aggregated socioeconomic status
The classification system uses
diagnosis for grouping
Demographic information
Diagnosis
Comorbidity using a grouper
Past healthcare consumption
*Groningen was not included in the table because the integrated care programmes do not use population-based health risk predictive modelling tools.
†The total population of Scotland is 5 295 000 inhabitants.
ACT, Advancing Care Coordination and Telehealth Deployment.
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status, is recommended as the ﬁrst milestone to enhance
clinical risk predictive modelling. In a second step, we
propose to incorporate the classiﬁcation of the individ-
ual in the risk stratiﬁcation pyramid as one of the covari-
ates of clinical risk predictive modelling. It is of note,
however, that prospective assessment of both practical-
ities and quantiﬁcation of the added value of the
proposed approach are needed but were beyond the
scope of the current research.
DISCUSSION
Summary of main findings
The results of the two surveys indicated a high degree of
conceptual agreement among the ﬁve ACT regions on
Table 2 Risk prediction strategies and characteristics of data reporting for the study on top indicators in the five ACT regions
Basque Catalonia Groningen Lombardy Scotland
Barriers for
comparison
Scope of the
stratification
strategy
Entire
population
(population
health)
Population
(population
health)
Programme
(population
medicine)
Programme
(population
medicine)
3.4 million
people (toward
population
health)
Heterogeneous
predictive modelling
tools
Current predictive
modelling tool
ACG-PM CRG Not available CReG, evolving
toward a risk
predictive
modelling tool
SPARRA v3
(owned by the
region)
Different statistics
describing predictive
power, different levels
of flexibility
Risk categories (%)*
High 1.3 3.4 – 3.0 0.7 Different criteria for risk
categories leading to
non-comparable
population distributions
Medium 5.5 10.8 – 40.9 2.0
Low 22.8 34.7 – 56.1 6.7
Healthy 70.4 51.1 – – 90.6
Characteristics of
reporting on top
indicators
Regional and
microsystems
Regional and
four areas
Three
programmes
GReG cohorts Subregion Heterogeneity of
reporting allowed
conceptual consensus
but not comparability of
results
*Estimations of risk-strata distribution corresponds to 2012.
ACG-PM, Adjusted Clinical Groups-Predictive Model; ACT, Advancing Care Coordination and Telehealth Deployment; CReG, Chronic-Related
Group; SPARRA V3, Scottish Patients at Risk of Readmission and Admission V.3.
Table 3 Recommendations for good practice population-based health risk assessment
Domain Recommendations
Level of
evidence
Type of risk stratification tool Predictive model using a population health approach High15–21
Validation of the model Longitudinal follow-up High41
Predicted/explained outcomes Unplanned hospital-related events; risk of institutionalisation; death; case
prognosis
High15–21
Source sample Whole regional population High15 16
Statistical model Predictive modelling High15–21
Statistical indices Standardisation on reporting performance (positive predictive value, PPV)41
and sensitivity across risk bands
Moderate41*
Population usefulness Risk adjustment; planning and commissioning health services
Support to novel reimbursement models
High22–24
Clinical and social usefulness Identification of patients at high risk and cost-effective preventive clinical
and social interventions
High15–22
Periodicity of updates Semester Low†
Clinical accessibility Available in the professional workstation through clinical decision support
systems
High‡
Flexibility and transferability Open algorithms, open source, reduced or no licence binding. Morbidity
grouper based on statistical criteria adjusted to the target population
High
*To report metrics indicating sensitivity/specificity of predictions is recommended for good practice. However, some regions adopt a pragmatic
approach classifying individuals into specific of the risk-strata pyramid without informing on sensitivity/specificity because of rather poor
robustness of predictions provided by most of the models.
†Periodicity of updates depends on the logistics available in each site. A yearly or 6-monthly basis seem reasonable.
‡Development of adequate clinical decision support systems (CDSS) depends on three main factors: (1) robustness of computational
modelling feeding the CDSS; (2) refinement of the CDSS generated by the clinical feedback and (3) appropriate dashboard providing a
user-friendly interface.
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the relevant role of population-based health risk assess-
ment for regional deployment of integrated care. The
entire ACT consortium shared its usefulness for service
commission, case ﬁnding and screening. There was also
consensus on the use of a population health approach15
as the optimal strategy for population-based risk
assessment.
However, the health risk predictive modelling tools in
place displayed marked heterogeneities that precluded
comparability of the risk pyramid distributions across
regions. Likewise, different well-identiﬁed problems
mostly associated with data reporting precluded appro-
priate comparisons of the recommended health indica-
tors described in the online supplementary material
table 1S.
The current study identiﬁed transferability across
regions and the potential for evolving, namely, ﬂexibility,
as two key requirements for any population-based health
risk assessment tool. Factors such as: (1) license binding
constraints, (2) insufﬁcient public availability, (3) lack of
availability for inspection and/or (4) rigidity of some
computational algorithms (ie, due to inclusion of
expert-based criteria in some morbidity groupers)—are
currently limiting transferability. These factors might
also preclude adaptation of the current risk prediction
tools toward evolving requirements such as: (1) integra-
tion between healthcare and social services and (2)
implementation of synergies between population-based
and clinically oriented risk predictive modelling, as
described in the study. The analysis of the GMA as a use
case (ﬁgure 1 and see online supplementary ﬁgure 3S)
seems to support the recommendations on innovation
on population-based health risk prediction, as displayed
in table 3.
We acknowledge some intrinsic limitations of
population-based predictive modelling in terms of robust-
ness of derived estimations. However, allocation of indivi-
duals into the risk stratiﬁcation pyramid based on this
approach seems to facilitate the design and implementa-
tion of sustainable and successful preventive strategies.
Along these lines, we forecast that recommendations
generated by the current study (table 3) will contribute
to strengthen evidence on the cost-effectiveness of
population-based risk predictive tools.
Moreover, the study reports on the conceptual steps
required for development of innovative strategies for
clinical risk predictive modelling with potential to
enhance its supporting role for decision-making in the
clinical scenario. We acknowledge, however, that further
studies evaluating feasibility, beneﬁts and applicability of
the proposals for enhanced clinical risk prediction are
needed.
Population-based health risk prediction
While the ACT project has conﬁrmed consensus on the
role initially ascribed to population-based health risk
assessment in regional deployment and adoption of inte-
grated care services, the core lesson learnt from the
current study is the need for innovative approaches to
risk predictive modelling. Our analysis suggests two basic
pillars for a future European extension: (1) implementa-
tion of the recommendations for risk predictive model-
ling tools displayed in table 3 and (2) ability to report
on the list of basic indicators depicted in the online
supplementary material. The current heterogeneities
among regions clearly indicate that adjustment of the
current settings to the recommended good practice will
require site-speciﬁc transitional strategies the common
goals and basic principles of which are described in the
current study. Key operational steps needed for practical
implementation of a regional strategy for population-
based health risk predictive modelling are summarised
in online supplementary table 4S.
There is a lively debate regarding management modal-
ities associated with generation and exploitation of
population-based health risk predictive modelling.
Should model generation and maintenance be publicly
funded (ie, Department of Health) or should there
simply be policies promoting open market in terms of
private suppliers of risk predictive tools?18 37 The
current study only emphasises the need for openness,
ﬂexibility and transferability of risk predictive modelling
in order to fulﬁl their core purposes. However, as stated
below, we acknowledge the complexities of the issue,
also involving ethical aspects. Doubtless, this issue will
require proper regulation irrespective of the ﬁnally
adopted business model.
Enhanced clinical health-risk assessment
The authors acknowledge that only a small proportion
of the huge potential of risk predictive modelling is cur-
rently applied for health forecasting purposes in the
clinical arena. A detailed description of the bottlenecks
constraining the developments recommended for
enhanced clinical risk predictive modelling, as proposed
in the current study, are reported elsewhere.38 Under
the subheading, we are highlighting only a few key
aspects that need attention to successfully accomplish
the roadmap proposed in the current study. No doubt
the milestones described above to explore the current
proposal for enhanced clinical risk prediction, in terms
of validation and implementation, constitute the ﬁrst
priority.
Toward personalised medicine
We believe that the current study contributes to paving
the way for a future holistic approach to risk predic-
tion.39 Such a strategy will consider multiple covariates
inﬂuencing patient health and should allow persona-
lised design medicine care pathways for chronically ill
patients.
Three categories of covariates have been identiﬁed to
show potential for inclusion into clinical risk predictive
modelling, as displayed in ﬁgure 2: (1) input from
enhanced case ﬁnding tools, that is, population-based
health risk predictive models, as mentioned above, (2)
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individual clinical, physiological and biological informa-
tion relevant to the medical problem being assessed,
and (3) subject-speciﬁc informal care data including life-
style, adherence proﬁle, socioeconomic status, require-
ments in terms of social support and environmental
factors. It is hypothesised that inclusion of all these cov-
ariates inﬂuencing patient health will markedly increase
the predictive accuracy and facilitate clinical decision-
making based on sound estimates of the prognosis of an
individual.
The three categories of covariates, as alluded to above,
shall be dynamically captured from different sources,
respectively: (1) population-based health risk predictive
models; (2) articulated healthcare and biomedical
research knowledge (integration of clinical, physiological
and biological/molecular information), and (3) in-place
personal health folders (lifestyle, adherence proﬁle,
socioeconomic status, social support and environmental
factors).
The implementation of speciﬁc solutions within a
Digital Health Framework, conceptually formulated ela-
sewhere,40 should have the potential to articulate the
three categories of variables, potentially allowing for
dynamic assessment of health risk both for population-
based purposes, as well as for speciﬁc clinical problems.
Nowadays, a Digital Health Framework, as depicted in
ﬁgure 3, is only a conceptual formulation, but it contains
the seeds to foster the concept of the ‘exposome’, as
deﬁned by Coughlin,39 which provides the basis for per-
sonalised medicine in chronic cases. There is no doubt
that the implementation of speciﬁc solutions within the
envisaged Digital Health Framework constitutes an ambi-
tious endeavour requiring a stepwise approach to effect-
ively overcome major challenges involved in the
transitional process to make it operational.
Enhanced applicability and integration of powerful
data analytics, including risk predictive modelling, into
clinical practice also constitutes a central goal of the
Figure 2 The dimensions of
patient health indicated in the
figure may contribute to enrich
clinical risk predictive modelling.
As a first step, we propose to
include the outcome of the
population-based risk
assessment as a covariate in
clinical risk predictive modelling.
For future personalised care for
chronic patients, enhanced
dynamic communication among
Informal Care, Health Care and
Biomedical Research will allow
inclusion of several dimensions
into clinical risk predictive
modelling. It will be carried out
through multilevel/multiscale
heterogeneous data integration
within a Digital Health Framework,
as depicted in figure 3.
Figure 3 Scheme of the Digital
Health Framework,40 composed
of digital data normalisation and
knowledge management layers
for knowledge generation, and
novel Clinical Decision Support
Systems (CDSS) embedded into
integrated care processes.
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above Digital Health Framework. In this regard, the
development of novel clinical decision support systems,
bolstered by advanced visual analytics, facilitating repre-
sentation of patient information for effective clinical
management of time-varying individualised data, is a
real yet unmet need to facilitate clinical judgement for
decision-making. Moreover, studies assessing the poten-
tial of different modalities of patient gateways, such as
the personal health folder, for patient self-management
purposes and for collection of informal care variables,
are urgently needed.
Finally, the novel healthcare scenario reveals new emer-
ging needs regarding highly relevant non-solved ethical
issues. These are related to privacy, security of data trans-
fer, as well as risks associated with healthcare decisions
that rely on inadequate risk predictive models. The com-
plexities involved in some of these aspects can only be
addressed through a democratic debate; openness and
transparency of the healthcare governance; as well as a
timely and appropriate evolution of legal frames.
CONCLUSIONS
The implementation of current recommendations for
population-health risk assessment, in terms of risk pre-
dictive modelling and health indicators, constitutes a pri-
ority for the on-going processes of adoption of
integrated care at the European level. The current study
proposes novel strategies for enhanced clinical risk
assessment and stratiﬁcation, together with a roadmap
for evaluation and future implementation of the novel
approach.
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